Figure 1.
Filovirus ward clinicians administering supportive treatment while concurrently recording clinical data during the Bundibugyo Uganda 2007–08 Ebola haemorrhagic fever outbreak.
Photo by Claude Mahoudeau.
Table 1.
Self-reported demographics, days before seeking treatment at an Ebola ward, and contact histories of 26 patients with laboratory-confirmed Ebola haemorrhagic fever, Bundibugyo District, Uganda (November 2007–February 2008).
Table 2.
Self-reported symptoms (15 patients), clinically observed symptoms (21 patients), and combined symptoms (26 patients) among hospitalised laboratory-confirmed EHF patients with known clinical outcome for whom data were recorded, Bundibugyo District, Uganda (November 2007–February 2008).
Figure 2.
Frequency of non-haemorrhagic symptoms from self-reported day of symptom onset to clinical outcome, as absolute numbers and percentages, among symptomatic (9 deceased and 12 surviving) laboratory-confirmed Ebola haemorrhagic fever patients, Bundibugyo District, Uganda, November 2007–February 2008.
Note changes in denominator between self-reported and clinically observed sections.
Figure 3.
Median duration in days of symptoms from self-reported onset until clinical outcome among 26 symptomatic laboratory-confirmed Ebola haemorrhagic fever patients, Bundibugyo District, Uganda (November 2007–February 2008).
Blue and red bars indicate general and haemorrhagic symptoms, respectively. *Day 0 = presentation to the Ebola ward. ‡Whiskers indicate maximum duration of the self-reported symptoms prior to presentation to the Ebola ward for patient observations >1. †Whiskers indicate maximum duration of the clinician-assessed symptoms at presentation to and during hospitalisation on the Ebola ward for patient observations >1. #Denominator contains female patients only (n = 9).
Figure 4.
Frequency of haemorrhagic symptoms from self-reported day of symptom onset to clinical outcome, as absolute numbers and percentages, among symptomatic (9 deceased and 12 surviving) laboratory-confirmed Ebola haemorrhagic fever patients, Bundibugyo District, Uganda, November 2007–February 2008.
Note changes in denominator between self-reported and clinically observed sections.
Table 3.
Treatment recorded for 19 hospitalised laboratory-confirmed Ebola haemorrhagic fever patients, by clinical outcome.